24 May 2013
Keywords: ranbaxy, revises, target, sales, indian, drugmaker, says
Article | 14 July 2003
Indian drugmaker Ranbaxy says that, following the success of its generic version of the antibiotic Augmentin (amoxicillin and clavulanate
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.
14 July 2003
23 May 2013
© 2013 thepharmaletter.com